Introduction {#sec1-1}
============

Regular exercise has been shown to have many health benefits, both physically and mentally. Indeed, it increases metabolic rate, helping in weight loss, improves whole-body glucose homeostasis and increases insulin sensitivity. Recently, endocrine factors called myokines, produced by skeletal muscles and released during the contraction of muscle fibers, have been detected and linked to the loss of fat mass through the activation of thermogenesis in adipose tissue.^[@ref1],[@ref2]^ Thermogenesis is a physiological process typical of uncoupling protein 1 (UCP1)-expressing mature brown adipocytes and recruitable brown-like adipocytes, the so-called beige or brite adipocytes.^[@ref3]^ In these cells, UCP1 uncouples the mitochondrial respiration from the production of adenosine triphosphate (ATP) and the energy produced by the catabolic pathways is released in form of heat.^[@ref4],[@ref5]^ Brown and beige adipocytes are morphologically distinct from white ones for having multiple small lipid droplets (LDs) instead of a unique fat depot that occupies the vast majority of the cytoplasm,^[@ref6]^ and for having a high number of mitochondria intimately associated to them.^[@ref7]^ It was also demonstrated that the gene expression pattern of the three cell types is very different; despite beige adipocytes may be seen as "intermediate" between white and brown adipocytes, they present a unique gene expression pattern with highly specific molecular markers.^[@ref8]^

This unique feature of UCP1-expressing cells has raised in recent years a great effort in brown adipobiology and obesity research, as the induction of browning by cold exposure, exercise and dietary/pharmacological factors may represent an effective way to counteract obesity and its related comorbidities.^[@ref12]^ In fact, many studies performed on both *in vitro* and *in vivo* models, which have been recently reviewed,^[@ref2]^ showed that the treatment with browninginducing factors increases energy expenditure by enhancing the expression of *Ucp1* gene and other brown adipose tissue (BAT) markers. Canonical BAT gene markers include the elongation of very long chain fatty acids protein 3 (*Elovl3*), cell deathinducing DNA fragmentation factor A (DFFA)-like effector A (*Cidea*), PR domain-containing protein 16 (*Prdm16*) and peroxisome proliferator-activating receptor (PPAR) γ coactivator 1α (*Ppargc1a*). These last two genes are deeply involved in mitochondrial biogenesis and in early BAT differentiation. ^[@ref8]^

The exercise-induced adaptive thermogenesis would not make sense in white adipose tissue (WAT), since exercise *per se* increases heat production.^[@ref13]^ Therefore, myokines, such as irisin, myostatin, meteorin- like 1 (Metrnl) and b-aminoisobutyric acid (BAIBA), which are released during muscle contraction in physical activity, are claimed as browning-promoting factors in WAT.

BAIBA is a non-protein amino acid originating from the catabolism of thymine and valine that plays a critical role in browning and in insulin resistance.^[@ref14],[@ref15]^ Recently, BAIBA has been shown to protect osteocytes against reactive oxygen species and related apoptosis.^[@ref16]^ Despite the role of myokines in WAT browning has been extensively reviewed,^[@ref2],[@ref13]^ the cellular pathways through which they exert their action are mostly unknown. Roberts and colleagues hypothesized a PPARα-mediated mechanism through which BAIBA positively affects lipid metabolism in both adipocytes and hepatocytes.^[@ref15]^ However, the exact molecular pathway of browning, as well as the remodelling of LDs induced by BAIBA needs further investigation.

This paper aims to show the effects of BAIBA treatment on murine 3T3-L1 preadipocytes during their differentiation to mature adipocytes on morphological and numerical changes of LDs and on the expression of a selected gene pattern. The expression of a core set of brown fat-specific genes and mitochondrial biogenesis (*Ucp1*, *Cidea*, *Elovl3*, *Ppargc1a*, *Prdm16* and *Cyc1*) and a beige marker (*Tbx1*) was analyzed. Markers of LD formation and dynamics such as perilipin 1 (*Plin1*) and cell death-inducing DFFA-like effector C (*Cidec*) were investigated. Finally, the expression of brain-derived neurotrophic factor (*Bdnf*), a neurotrophin, which has a role in browning on *in vivo* models and in regulating energy balance and insulin signaling, ^[@ref17],[@ref18]^ was also assessed.

Materials and Methods {#sec1-2}
=====================

Chemicals and culture media {#sec2-1}
---------------------------

Dulbecco's modified Eagle medium (DMEM) enriched with 4.5 g/L D-glucose, 110 mg/L sodium pyruvate and 862 mg/L L-alanyl-L-glutamine (GlutaMAX™), DMEM/F-12 (1:1) medium enriched with GlutaMAX™ and 15 mM 4-(2-hydroxyethyl)- 1-piperazineethanesulfonic acid (HEPES), fetal bovine serum (FBS), penicillin/ streptomycin solution and amphotericin B solution were purchased from Gibco by Life Technologies (Thermo Fisher Scientific Inc., Waltham, MA, USA). Rosiglitazone was purchased from Cayman Chemical (Ann Arbor, MI, USA). BAIBA was purchased in a racemic mixture from AdipoGen SA (AdipoGen Life Science Inc., San Diego, CA, USA). Dipyrromethene boron difluoride (BODIPY) 493/503 dye, TRIzol reagent, PureLink™ RNA Mini Kit and Platinum™ SYBR™ Green qPCR SuperMix-UDG kit for real time PCR were purchased from Invitrogen (Thermo Fisher Scientific Inc.). ImProm-II™ Reverse Transcription System was purchased from Promega (Madison, WI, USA). 4,6- diamidin-2-phenylindole (DAPI)-containing mounting medium was purchased from Abcam (Cambridge, MA, USA). All other chemicals used in the experiment and not listed above were purchased from Sigma- Aldrich (Darmstadt, Germany).

Cell culture and treatment {#sec2-2}
--------------------------

3T3-L1 cells were chosen in the present study for their extensive use in evaluating the effects of compounds or nutrients on adipogenesis and in the potential application of various compounds and nutrients in the treatment of obesity. Moreover, at the best of our knowledge, the browning effect of BAIBA on 3T3-L1 cell model was never investigated. The murine 3T3-L1 preadipocytes (ZenBio Inc., Durham, NC, USA) were grown in high glucose DMEM supplemented with 10% FBS, 1% amphotericin B solution and 1% penicillin/streptomycin solution, at 37 °C with 5% CO~2~ and 95% relative humidity. Differentiation was induced 48 h after cells reached full confluence with DMEM/F-12 medium supplemented with 10% FBS, 1% amphotericin B solution, 1% penicillin/streptomycin solution, 0.5 μg/mL human insulin, 5 μM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 1 nM triiodothyronine (T~3~) and 1 μM rosiglitazone. After 3 days, the differentiation medium was switched to a maintenance medium to which 0.5 μg/mL human insulin and 1 nM T~3~ were added. Maintenance medium was refreshed every 2 days. After the switch from differentiation to maintenance medium, cells were treated with 1, 3 and 5 μM BAIBA until analysis. Cells were analyzed during differentiation at day 4 (4d) and at day 8 (8d), at day 10 (10d); these time points correspond to 2, 6 and 8 days of BAIBA treatment, respectively. A negative vehicle control (CTRL) was established treating cells with sterile milliQ water.

Cell viability assay {#sec2-3}
--------------------

Cell viability was determined by 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Medium was removed from cells plated on a 96-well plate and treated with different concentrations of BAIBA. Prior to incubation with 5 mg/mL MTT solution in Hank's balanced salt solution (HBSS), cells were rinsed with phosphate buffer saline (PBS) 1x. Incubation with MTT solution was performed at 37°C for 4 h. Accumulated formazan was dissolved in dimethyl sulfoxide (DMSO) and incubated overnight at 37°C. The optical density was used as an indicator of cell viability and was measured at 550 nm.

BODIPY staining {#sec2-4}
---------------

After cell fixation in a 2% formalin solution diluted in PBS 1x at room temperature (RT) for 15 min, the slides were washed three times in PBS 1x and then incubated in a solution of BODIPY493/503 in PBS 1x to fluorescently label lipid droplets. The incubation was performed at RT in dark for 45 min. After the incubation, the slides were washed in PBS 1x three times and then mounted with mounting medium with DAPI. Images were acquired with the fluorescence microscope Axio Observer Z1 equipped with D-PLAN Neofluar objective lenses with N.A. 0.75 and Infinity Color Corrected System (ICS) and with AxioCam and Zen blue software (Carl Zeiss, Jena, Germany). The filters used for BODIPY were 470/525 nm, and 390/460 nm for DAPI.

Morphology of LDs {#sec2-5}
-----------------

MRI_Lipid Droplets tool (<http://dev.mri.cnrs.fr/projects/imagejmacros/wiki/LipidDroplets_Tool>), a macro of ImageJ1.50b software (<http://rsb.info.nih.gov/ij/>), was used to measure LD area.^[@ref19]^ The images were analyzed as already described.^[@ref20]^ For each LD area, perimeter, maximum Feret diameter (MFD) and integrated optical density (IOD) were measured. MFD is defined as the maximum distance between the two parallel planes restricting the object perpendicular to that direction and is a measure of an object size along a specified direction. It is generally used in optical microcopy to measure the size of particles.^[@ref21],[@ref22]^ The IOD reports the average intensity/density of each object and increases linearly with the triglycerides content in 3T3-L1 adipocytes.^[@ref23]^

Total area occupied by LDs in each field at different days of differentiation was calculated by summing up the area of each LD. The count of cells in each field was used to calculate the area and the number of LDs per cell. The average area of a single LD was calculated by dividing the area of LDs/cells by the number of LDs/cells. The area (μm^[@ref2]^) and number of LDs were measured and counted on 15 fields for each time point.

A nonparametric representation of the LDs size probability density function (kernel) was chosen to avoid making assumptions about the distribution of the data; the kernel size distribution was evaluated with a routine written in Matlab 7.1 (Mathworks, MA, USA).

Of note, 2D examination of the LDs, which are 3D objects, leads to an underestimation of the size of bigger LDs with respect to smaller LDs, increasing the probability to detect the first ones. Despite this approach could affect the absolute kernel density distribution of the LDs size, it is used here in order to obtain a relative comparison only between different populations.

RNA extraction and RT-PCR {#sec2-6}
-------------------------

After culture medium removal from 6- well plates, 1 mL/10 cm^[@ref2]^ of TRIzol reagent was added in each well and repeatedly pipetted to induce a severe breakdown of cell structures. These samples were immediately processed with the PureLink™ RNA Mini Kit following the manufacturer's instructions.

The concentration of the extracted total RNA was quantified using a spectrophotometer (NanoDrop 1000 Spectropho-tometer; ThermoScientific, Wilmington, DE, USA) and the purity of RNA samples ranged between 1.8 and 1.9. RNA integrity was evaluated through the observation of 18S and 28S ribosomal bands after electrophoresis on 1% agarose gel, in the presence of GelRed. Primer3 Input software was used to design primers.^[@ref24]^ GenBank accession, primer sequences, product lengths and relative annealing temperatures for each gene are listed in [Table 1](#table001){ref-type="table"}, according to the HUGO Gene Nomenclature Committee.

Total RNA (500 ng) from each sample was reverse-transcribed and amplified using an MJ thermal cycler (PT-100; MJ Research, Inc., Waltham, MA, USA). For each gene, an aliquot of cDNA samples were pooled and standard curves with serial dilution of pool were used to optimize PCR conditions and to calculate the efficiency, fluorescence baseline and threshold. Real time PCRs were performed for each sample in triplicate form using Platinum® SYBR® Green qPCR SuperMix-UDG. cDNA concentrations and primers molarities were different for each gene and determined with standard curves analyses. PCR amplification was conduced applying 45 cycles (1 sec at 95.C, 30 sec at the specific annealing temperature, 30 sec at 72.C) in a 96-well spectrofluorometric thermal cycler (CFX, Biorad, Milan Italy). The melting curve analysis of amplification products was performed at the end of each PCR reaction to confirm that a single PCR product was detected.

The expression of target genes was normalized using the TATA box-binding protein (*Tbp*) mRNA levels or geometric means between *Tbp* and glyceraldehyde 3- phosphate dehydrogenase (*Gapdh*) genes and analyzed using DDCt method.^[@ref25]^ For all the cell culture experiments, the results are generated from biological triplicates and represent similar results from at least three independent experiments.

Statistical analysis {#sec2-7}
--------------------

Results are presented as relative values (means ± SEM). All experiments were performed at least three times. Two-way ANOVA was used for statistical analysis for MTT test by SPSS ver. 20.0 software. The measurements of the area of LDs/cell, number of LDs/cell and the area of a single LD were analyzed by SPSS ver. 20.0 software. The results, obtained from ten biological replicates, were compared using Kruskal- Wallis statistical test followed by pairwise comparisons using the Mann-Whitney approach.

Results {#sec1-3}
=======

Cell viability {#sec2-8}
--------------

The percentage of cell viability after exposure of BAIBA at 4d, 8d and 10d was always around 100% (*data not shown*). No significant differences were observed for time point and for concentration x time point interaction.

Lipid droplet distribution and analysis {#sec2-9}
---------------------------------------

[Figure 1](#fig001){ref-type="fig"} illustrated LDs formation in 3T3-L1 cells at 4d, 8d and 10d in presence of different BAIBA doses. Interestingly, at 4d with 3 and 5 mM of BAIBA, cells showed very small LDs ([Figure 1](#fig001){ref-type="fig"}, panels g and l, respectively) in comparison to CTRL cells ([Figure 1a](#fig001){ref-type="fig"}).

Indeed, kernel densiy distribution suggested an high number of cells with a small Feret diameter when incubated with 5 mM of BAIBA after 4 and 10 days of differentiation ([Figure 2a](#fig002){ref-type="fig"}). The kernel distributions of MFD at 4d, 8d and 10d are shown in [Figure 2a](#fig002){ref-type="fig"}. For all the three time points, LD size distribution of the treated cells is similar to that of control cells. In particular, using the least squares method evaluated on 100 equally spaced Feret dimensions, the differences at 4d between control and the treatments (1 mM, 3 mM and 5 mM) are respectively 0.0045, 0.0047 and 0.0538; at 8d are 0.0106, 0.0075 and 0.0062; at 10d are 0.0367, 0.0807 and 0.0736. [Figure 2b](#fig002){ref-type="fig"} evidenced statistically significant differences of IOD, number of LDs/cell and area of a single LD/cell at 4d in presence of different BAIBA doses. To avoid any technical or biological variance due to cell number among slides, the total LD area was normalized to the number of cells.

The IOD significantly (P\<0.05) decreased between 3 mM and 5 mM, the number of LDs/cell increased between CTRL and 1 mM (P\<0.05) and between CTRL and 5 mM (P\<0.01). The area of a single LD/cell was significantly different between CTRL and 5 mM (P\<0.001). [Figure 2b](#fig002){ref-type="fig"} evidenced statistically significant differences in the area of LDs at 10d. In particular, the area was higher (P\<0.05) in CTRL and 3 mM in comparison to 5 mM. No statistical differences were found at 8d.

The decrease in IOD, which is inversely related with the amount of triglycerides in LDs, the lowest area of a single LD and the increase of the number of LDs/cell observed with 5 mM BAIBA at 4d can account for a LD generation through the lipolytic release of fatty acids.

Transcription data analysis {#sec2-10}
---------------------------

[Figure 3](#fig003){ref-type="fig"} indicated the relationship between the different concentrations of BAIBA and the significant differentially expressed genes at 4d and 8d, respectively. At 10d, gene expression did not display any significant variation. Only significant differentially expressed genes were showed. At 4d the expression of *Tbx1* was significantly (P\<0.05) different between 5 mM and lower doses. No significant differences were found with CTRL, maybe due to the high variability at the 5 mM dose. *Ppargc1a* (P\<0.05) *Prdm16*, and *Bdnf* were up-regulated (P\<0.002) at the same dose, while *Ppara* displayed significant differences for 1 mM and 5 mM in comparison to CTRL and 3 mM ([Figure 3a](#fig003){ref-type="fig"}). *Cidea* was significantly upregulated (P\<0.05) at 5 mM, whereas *Plin1* showed the significantly (P\<0.05) lowest expression at 5 mM in comparison to CTRL ([Figure 3b](#fig003){ref-type="fig"}).The expression of *Ppargc1a*, *Ucp1* and *Ppara* (P\<0.001) was at its highest with 1 and 3 mM BAIBA doses in comparison to CTRL and 5 mM ([Figure 3c](#fig003){ref-type="fig"}).

Discussion {#sec1-4}
==========

The present study reports the browning effect of BAIBA at different concentrations on 3T3-L1 cells at 4, 8 and 10 days of differentiation. It provides evidence showing the dynamics of LD morphology together with the expression of a panel of genes related to adaptive thermogenesis and LD formation. Although it is well established that this molecule, secreted by myocytes during exercise and circulating in blood, triggers the browning of WAT, no studies were conducted after its description by Roberts *et al*. in 2014.^[@ref15]^ This study tested for the first time on 3T3-L1 cells known as reliable cellular model used in obesity researches, the browning effect of BAIBA by measuring variations in morphology of LDs that have recently attracted great interest as dynamic structures at the hub of lipid and energy metabolism.

It is largely known that brown adipocytes are occupied by multilocular LDs to facilitate the efficiency of lipases and subsequent uncoupling in response to cold or other stimuli.^[@ref26]^ Recently, changes in LD dimension and in their associated proteins, such as CIDEC, CIDEA and PLIN1, have been demonstrated after the stimulation of browning.^[@ref6]^ In the present study, statistical analysis evidenced that at 4 days of differentiation and at the highest BAIBA concentration, the number of LDs per cell increased in comparison to control cells, whereas the surface area of a single LD significantly decreased. The decrease of IOD observed at the same time and concentration suggested a smaller triglyceride accumulation compared to controls. Interestingly these results occurred at 4 days of differentiation, that correspond to the peak of lipogenesis.^[@ref27]^ The results on LD morphology at 4d were corroborated by gene expression analysis. The browning adaptation included the up-regulation of *Ppargc1a*, *Tbx1*, *Ucp1*, *Cidea*, *Elovl3* and *Prdm16*. In particular, 5 mM BAIBA at 4d influenced the expression of *Tbx1* ([Figure 3a](#fig003){ref-type="fig"}), while the expression of *Ucp1* was induced after 8 days of differentiation ([Figure 3c](#fig003){ref-type="fig"}). This is in agreement with the results obtained on human primary subcutaneous adipocytes treated with irisin, a myokine with dubious potential role in inducing browning of white adipose tissue. ^[@ref28],[@ref29]^ Moreover, a significant increase of *Cidea* with 5 mM BAIBA treatment ([Figure 3b](#fig003){ref-type="fig"}), but not of *Cidec*, was observed, as reported in cells obtained by primary stromal vascular fraction of inguinal WAT of mice.^[@ref15]^ *Cidea* is known as a brown adipocyte specific gene, related to multilocular phenotype,^[@ref8]^ and it is induced in WAT following cold exposure or β-adrenergic signaling.^[@ref6],[@ref30]^ In fact, the highest surface/volume ratio of smaller LDs increases the contact area of the LD with lipases and the subsequent facilitation of free fatty acids transport to mitochondria. CIDEA and CIDEC proteins are involved together in the fusion and enlargement of LDs, but while CIDEC is crucial in the formation of large LD in WAT, CIDEA alone is not sufficient.^[@ref27]^ Recently, Nishimoto et al demonstrated that, in BAT, an isoform of CIDEC inhibits the homo dimerization of CIDEA and suppresses the formation of large LDs.^[@ref31]^ As further evidence of browning effect induced by BAIBA at 4d, *Plin1* gene was significantly down-regulated by all treatments in comparison to control ([Figure 3b](#fig003){ref-type="fig"}). In fact, perilipin 1 cooperates with CIDEC, but not with CIDEA, in inducing a super-sized, unilocular LD.^[@ref32]^

After 4 days of differentiation, the expression of *Ppargc1a* and *Prdm16* was also significantly increased by 5 mM BAIBA. This is in line with *in vivo* experiments that showed that exercise training has marked effects on mitochondrial gene expression and activity in subcutaneous WAT in mice and human.^[@ref33]^ *Ppargc1a* controls mitochondrial biogenesis and heat production through induction of expression of *Ucp1* and other respiratory factors.^[@ref34]^ The higher expression level of this gene and *Prdm16*, a classic marker of brown fat, at 4d and later at 8d is coherent with the followed higher transcription of *Ucp1* ([Figure 3c](#fig003){ref-type="fig"}).

PPARα, a nuclear receptor, stimulates genes involved in mitochondrial fatty acid oxidation and increases the expression of *Ucp1* by directly interacting with *Ppargc1a* in primary murine brown adipocytes.^[@ref35]^ Roberts *et al*. demonstrated that browning process induced by BAIBA involved a specific *Ppara*-dependent mechanism,^[@ref15]^ without clarifying the upstream mechanism of action. Very recently, it has been shown that the loss of *Ppara* affected mature brown adipocytes by reducing the expression of brown markers *in vitro* but not *in vivo*, suggesting as well an important role of glycerol kinase in maintaining the activity of PPAR proteins.^[@ref36]^ Moreover, it should be considered that PPARα regulates *Cidea* in mouse liver without altering the expression of *Ucp1*.^[@ref37]^ In the present paper, the expression of *Ppara* is induced by 5 mM BAIBA at 4d and its expression was further increased at 8d with the lowest BAIBA concentration, as well as the expression of *Ppargc1a* and *Ucp1* ([Figure 3c](#fig003){ref-type="fig"}). However, at 8d no significant variations in LD morphology and number were appreciated, as observed in PPARγ2-programmed cells treated with BAIBA.^[@ref15]^ At 10d, BAIBA treatments did not significantly affect gene expression, although a decrease in the area of LDs was detected at the highest dose ([Figure 3d](#fig003){ref-type="fig"}).

BDNF is a neurotrophin expressed in brain, which regulates neuronal development and plasticity. However, it was also found in non-neuronal tissues, such as WAT and BAT in rodents and cows,^[@ref38],[@ref39]^ where it could be involved in fat metabolism and in the activation of the sympathetic response.^[@ref39],[@ref40]^ Moreover, mRNA and protein BDNF expression increases in human skeletal muscle after exercise, suggesting a role, as a myokine, on skeletal muscle metabolism,^[@ref41]^ by enhancing local and peripheral fatty acid oxidation.^[@ref42]^ The action of BAIBA at 4d on 3T3-L1 cells increased the *Bdnf* expression ([Figure 3a](#fig003){ref-type="fig"}), which in turn activates AMPK,^[@ref43]^ thus facilitating the browning conversion.

This paper demonstrated that BAIBA promotes browning phenotype on 3T3-L1 cells during first 4-8 days of differentiation. In agreement with Roberts *et al*.^[@ref15]^ the highest concentration during the early days of differentiation produced the strongest effect on cells in terms of LD dynamics and expression of beiging gene markers. After 8 days of differentiation, no changes were identified on LD morphology, although a browning effect was achieved as observed by brown gene marker expression. This browning effect appeared to be lost in cells after 10 days of differentiation.

The action of BAIBA significantly affects the early stage of adipocyte differentiation and can reflect a rapid adaptation of adipose tissue to physical exercise. This connection stresses the beneficial impact of physical exercise on metabolic health, providing more evidence of the preventive and therapeutic role of physical activity against obesity.

![Lipid droplet pattern (stained with BODIPY 493/503) in fixed 3T3-L1 cells at 4d (a,d,g,l), 8d (b,e,h,m), and 10d (c,f,i,n). Control cells (a,b,c) and cells treated with 1 mM (d,e,f ), 3 mM (g,h,i) and 5 mM (l,m,n) of BAIBA are shown. Nuclear staining DAPI. Images are representative of n. 5 biological replicates. Scale bars: 20 mm.](ejh-62-4-2984-g001){#fig001}

![a) Kernel distribution of the Feret of the lipid droplets at 4, 8 and 10 days of differentiation in control and BAIBA-treated cells. b) Lipid droplet measurements on 3T3-L1 in presence of different BAIBA doses: Integrated optical density (IOD), number of LDs per cell, area of single LD after 4 days of differentiation and total area of LD and after 10 days of differentiation. Box plots show median (horizontal lines), first-to-third quartile (box), and the extreme values with the interquartile range (vertical lines). The area measures are expressed in mm^[@ref2]^ and are the average of 10 fields of each concentration. \*\*\*P\<0.001, \*\*P\<0.05.](ejh-62-4-2984-g002){#fig002}

![Differentially expressed genes between BAIBA doses after 4 and 8 days of differentiation. a) Genes involved in browning (three biological replicates) at 4d. *Tbx1*, T-box 1; *Ppargc1a*, peroxisome proliferator-activated receptor γ coactivator 1 α; *Ppara*, peroxisome proliferator-activated receptor α; *Prdm16*, proline rich domain containing 16; *Bdnf*, brain derived neurotrophic factor. b) Lipid droplets related genes at 4d. *Cidea*, cell death-inducing DFFA-like effector A; *Plin1*, perilipin 1. c) Genes involved in browning (three biological replicates) at 8d. *Ucp1*, uncoupling protein 1. Bars represent the mean plus/minus standard error of the mean (SEM). \*P\<0.05; \*\*P\<0.01; \*\*\*P\<0.001.](ejh-62-4-2984-g003){#fig003}

###### 

Oligonucleotide primer sequences for RT-PCR.

  -----------------------------------------------------------------------------------------------------------
  Gene         GenBank accession   Primer sets                                Product length (bp)   Tm (°C)
  ------------ ------------------- ------------------------------------------ --------------------- ---------
  *Tbp*        NM_013684.3         Forward: 5'-CCAATGACTCCTATGACCCCTA-3'\     104                   58.5
                                   Reverse: 5'-CAGCCAAGATTCACGGTAGAT-3'                             

  *Gapdh*      NM_008084           Forward: 5'-AATGTGTCCGTCGTGGATCTGA-3'\     117                   60
                                   Reverse: 5'-AGTGTAGCCCAAGATGCCCTTC-3'                            

  *Ucp1*       NM_009463.3         Forward: 5\'-CTTTGCCTCACTCAGGATTGG-3'\     123                   59.8
                                   Reverse: 5\'-ACTGCCACACCTCCAGTCATT-3'                            

  *Ppargc1a*   NM_008904.2         Forward: 5\'-TATGGAGTGACATAGAGTGTGCT-3'\   191                   60.0
                                   Reverse: 5\'-CTGGGCAAAGAGGCTGGTC-3'                              

  *Cidea*      NM_007702.2         Forward: 5-ATCACAACTGGCCTGGTTACG-3'\       136                   58.9
                                   Reverse: 5'-TACTACCCGGTGTCCATTTCT-3'                             

  *Cidec*      NM_178373.4         Forward: 5'-ACCTTCGACCTGTACAAGCT-3'\       99                    58.4
                                   Reverse: 5'-GTGCAGGTCATAGGAAAGCG-3'                              

  *Elovl3*     NM_007703.2         Forward: 5\'-TTCTCACGCGGGTTAAAAATGG-3'\    139                   58.9
                                   Reverse: 5\'-GGCCAACAACGATGAGCAAC-3'                             

  *Cyc1*       NM_025567.3         Forward: 5'-GGCATCAGAACCAGAGCATG-3'\       110                   59.4
                                   Reverse: 5'-CTGACCACTTATGCCGCTTC-3'                              

  *Plin1*      NM_175640.2         Forward: 5\'-TGGACCACCTGGAGGAAAAG-3'\      94                    60.6
                                   Reverse: 5\'-CTTCGAAGGCGGGTAGAGATG-3'                            

  *Prdm16*     NM_027504.3         Forward: 5\'-CCACCAGCGAGGACTTCAC-3'\       107                   61.4
                                   Reverse: 5\'-GGAGGACTCTCGTAGCTCGAA-3'                            

  *Ppara*      NM_011144.6         Forward: 5 -TCTGTCGGGATGTCACACAA-3\        191                   57.3
                                   Reverse: 5 -CGGGCTTTGACCTTGTTCAT-3                               

  *Bdnf*       NM_007540.4         Forward: 5'-ATTACCTGGATGCCGCAAAC-3'\       241                   58.5
                                   Reverse: 5'-CCTTCCTTGGTGTAACCCAT-3'                              

  *Tbx1*       NM_011532.2         Forward: 5'-AGGCGGAAGGAAGTGGTATT-3'\       118                   58.4
                                   Reverse: 5'-TACCAGTATCTACACCGCCC-3'                              
  -----------------------------------------------------------------------------------------------------------

T~m~, annealing temperature; *Tbp*; TATA box binding protein; *Gapdh*, glyceraldehyde-3-phosphate dehydrogenase; *Ucp1*, uncoupling protein 1; *Ppargc1a*, peroxisome proliferator-activated receptor coactivator 1 α; *Cidea*, cell death-inducing DFFA-like effector A; *Cidec*, cell death inducing DFFA like effector C; *Elovl3*, elongation of very long chain fatty acids protein 3; *Cyc1*, cytochrome C1; *Plin1*, perilipin 1; *Prdm16*, proline rich domain containing 16; *Ppara*, peroxisome proliferator-activated receptor α; *Bdnf*, brain derived neurotrophic factor; *Tbx1*, T-box 1.
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